Component

D-chiro-inositol

D-chiro-inositol. Species, exposure and limitations are retained in each linked claim.

8 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. More than 98% of dietary D-chiro-inositol equivalents from the tested rodent diet, purified pinitol or labeled D-chiro-inositol were absorbed in rat balance experiments.

    D-chiro-inositol → D-chiro-inositol uptake source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/19586572.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26", "start_char": 0, "end_char": 1544, "text_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26"}
    experimental_model
    Dietary balance, GC-MS and stable-isotope tracing
    exposure
    Defined diets, heavy water and deuterated myo-inositol/DCI
    limitations
    Failure to detect conversion in mice does not exclude all human or isolated-tissue activity. Isotope strategy, chemical identification, species and dietary DCI contamination may contribute to disagreement with earlier radiotracer reports.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Rats and mice; conversion tracing in mice
    plain_language
    Diet itself can supply substantial D-chiro-inositol and confound attempts to measure its synthesis.
    primary_references
    [ino-p19586572] d- chiro-Inositol is absorbed but not synthesised in rodents. (2009). https://pubmed.ncbi.nlm.nih.gov/19586572/ DOI: 10.1017/s0007114509990456
    tissue_or_cell_type
    Gastrointestinal absorption, plasma and excreta

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1237–1248

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Dietary balance, GC-MS and stable-isotope tracing · source_derived_draft · unverified_draft

    ### ino-dci-absorption More than 98% of dietary D-chiro-inositol equivalents from the tested rodent diet, purified pinitol or labeled D-chiro-inositol were absorbed in rat balance experiments. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: Diet itself can supply substantial D-chiro-inositol and confound attempts to measure its synthesis. organism: Rats and mice; conversion tracing in mice tissue_or_cell_type: Gastrointestinal absorption, plasma and excreta experimental_model: Dietary balance, GC-MS and stable-isotope tracing limitations: Failure to detect conversion in mice does not exclude all human or isolated-tissue activity. Isotope strategy, chemical identification, species and dietary DCI contamination may contribute to disagreement with earlier radiotracer reports. exposure: Defined diets, heavy water and deuterated myo-inositol/DCI evidence_span: {"source_cache": "artifacts/inositol-research/19586572.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26", "start_char": 0, "end_char": 1544, "text_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26"} [ino-p19586572] d- chiro-Inositol is absorbed but not synthesised in rodents. (2009). https://pubmed.ncbi.nlm.nih.gov/19586572/ DOI: 10.1017/s0007114509990456
    Complete structured claim and evidence
  2. DCI in mouse plasma, stool and urine fell to very low levels on the pinitol/DCI-depleted diet, whereas levels remained stable on standard chow.

    D-chiro-inositol → Measured D-chiro-inositol pool source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    nutrient_deficiency Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/inositol-research/19586572.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26", "start_char": 0, "end_char": 1544, "text_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26"}
    experimental_model
    Dietary balance, GC-MS and stable-isotope tracing
    exposure
    Defined diets, heavy water and deuterated myo-inositol/DCI
    limitations
    Failure to detect conversion in mice does not exclude all human or isolated-tissue activity. Isotope strategy, chemical identification, species and dietary DCI contamination may contribute to disagreement with earlier radiotracer reports.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Rats and mice; conversion tracing in mice
    plain_language
    The measured pool depended strongly on dietary input in this experiment.
    primary_references
    [ino-p19586572] d- chiro-Inositol is absorbed but not synthesised in rodents. (2009). https://pubmed.ncbi.nlm.nih.gov/19586572/ DOI: 10.1017/s0007114509990456
    tissue_or_cell_type
    Gastrointestinal absorption, plasma and excreta
    trigger_kind
    nutrient_deficiency Imported condition classification; unverified.

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1250–1261

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Dietary balance, GC-MS and stable-isotope tracing · source_derived_draft · unverified_draft

    ### ino-dci-diet-depletion DCI in mouse plasma, stool and urine fell to very low levels on the pinitol/DCI-depleted diet, whereas levels remained stable on standard chow. Condition category: nutrient_deficiency nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: The measured pool depended strongly on dietary input in this experiment. organism: Rats and mice; conversion tracing in mice tissue_or_cell_type: Gastrointestinal absorption, plasma and excreta experimental_model: Dietary balance, GC-MS and stable-isotope tracing limitations: Failure to detect conversion in mice does not exclude all human or isolated-tissue activity. Isotope strategy, chemical identification, species and dietary DCI contamination may contribute to disagreement with earlier radiotracer reports. exposure: Defined diets, heavy water and deuterated myo-inositol/DCI evidence_span: {"source_cache": "artifacts/inositol-research/19586572.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26", "start_char": 0, "end_char": 1544, "text_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26"} [ino-p19586572] d- chiro-Inositol is absorbed but not synthesised in rodents. (2009). https://pubmed.ncbi.nlm.nih.gov/19586572/ DOI: 10.1017/s0007114509990456
    Complete structured claim and evidence
  3. Insulin-area reduction was significant within the D-chiro-inositol group, but the difference in change versus placebo had P=0.07.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/10219066.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854", "start_char": 0, "end_char": 2121, "text_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854"}
    experimental_model
    Randomized placebo-controlled trial
    exposure
    D-chiro-inositol 1200 mg/day for 6–8 weeks versus placebo; historical study regimen
    limitations
    Small short trial, not live-birth evidence. Within-group insulin improvement was stronger than the between-group comparison.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Homo sapiens
    plain_language
    Improvement within one group alone was not a conventionally significant between-group result.
    primary_references
    [ino-p10219066] Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. (1999). https://pubmed.ncbi.nlm.nih.gov/10219066/ DOI: 10.1056/nejm199904293401703
    tissue_or_cell_type
    44 obese women with PCOS

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1302–1313

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled trial · source_derived_draft · unverified_draft

    ### ino-dci-insulin-uncertain Insulin-area reduction was significant within the D-chiro-inositol group, but the difference in change versus placebo had P=0.07. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: Improvement within one group alone was not a conventionally significant between-group result. organism: Homo sapiens tissue_or_cell_type: 44 obese women with PCOS experimental_model: Randomized placebo-controlled trial limitations: Small short trial, not live-birth evidence. Within-group insulin improvement was stronger than the between-group comparison. exposure: D-chiro-inositol 1200 mg/day for 6–8 weeks versus placebo; historical study regimen evidence_span: {"source_cache": "artifacts/inositol-research/10219066.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854", "start_char": 0, "end_char": 2121, "text_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854"} [ino-p10219066] Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. (1999). https://pubmed.ncbi.nlm.nih.gov/10219066/ DOI: 10.1056/nejm199904293401703
    Complete structured claim and evidence
  4. The reduction in free testosterone differed from placebo in the small D-chiro-inositol trial (P=0.006).

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/10219066.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854", "start_char": 0, "end_char": 2121, "text_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854"}
    experimental_model
    Randomized placebo-controlled trial
    exposure
    D-chiro-inositol 1200 mg/day for 6–8 weeks versus placebo; historical study regimen
    limitations
    Small short trial, not live-birth evidence. Within-group insulin improvement was stronger than the between-group comparison.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Homo sapiens
    plain_language
    One androgen measure improved in this specific study.
    primary_references
    [ino-p10219066] Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. (1999). https://pubmed.ncbi.nlm.nih.gov/10219066/ DOI: 10.1056/nejm199904293401703
    tissue_or_cell_type
    44 obese women with PCOS

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1315–1326

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled trial · source_derived_draft · unverified_draft

    ### ino-dci-testosterone The reduction in free testosterone differed from placebo in the small D-chiro-inositol trial (P=0.006). Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: One androgen measure improved in this specific study. organism: Homo sapiens tissue_or_cell_type: 44 obese women with PCOS experimental_model: Randomized placebo-controlled trial limitations: Small short trial, not live-birth evidence. Within-group insulin improvement was stronger than the between-group comparison. exposure: D-chiro-inositol 1200 mg/day for 6–8 weeks versus placebo; historical study regimen evidence_span: {"source_cache": "artifacts/inositol-research/10219066.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854", "start_char": 0, "end_char": 2121, "text_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854"} [ino-p10219066] Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. (1999). https://pubmed.ncbi.nlm.nih.gov/10219066/ DOI: 10.1056/nejm199904293401703
    Complete structured claim and evidence
  5. Ovulation occurred in 19/22 D-chiro-inositol recipients versus 6/22 placebo recipients in the 1999 PCOS trial.

    D-chiro-inositol → Ovulation source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/10219066.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854", "start_char": 0, "end_char": 2121, "text_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854"}
    experimental_model
    Randomized placebo-controlled trial
    exposure
    D-chiro-inositol 1200 mg/day for 6–8 weeks versus placebo; historical study regimen
    limitations
    Small short trial, not live-birth evidence. Within-group insulin improvement was stronger than the between-group comparison.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Homo sapiens
    plain_language
    This small trial found more ovulation with D-chiro-inositol; it did not establish improved live birth.
    primary_references
    [ino-p10219066] Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. (1999). https://pubmed.ncbi.nlm.nih.gov/10219066/ DOI: 10.1056/nejm199904293401703
    tissue_or_cell_type
    44 obese women with PCOS

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1289–1300

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled trial · source_derived_draft · unverified_draft

    ### ino-dci-trial Ovulation occurred in 19/22 D-chiro-inositol recipients versus 6/22 placebo recipients in the 1999 PCOS trial. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: This small trial found more ovulation with D-chiro-inositol; it did not establish improved live birth. organism: Homo sapiens tissue_or_cell_type: 44 obese women with PCOS experimental_model: Randomized placebo-controlled trial limitations: Small short trial, not live-birth evidence. Within-group insulin improvement was stronger than the between-group comparison. exposure: D-chiro-inositol 1200 mg/day for 6–8 weeks versus placebo; historical study regimen evidence_span: {"source_cache": "artifacts/inositol-research/10219066.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854", "start_char": 0, "end_char": 2121, "text_sha256": "2b70007c28cc93c6f18b457701ec8b034a3bbe888db05e85eca71d50199dc854"} [ino-p10219066] Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. (1999). https://pubmed.ncbi.nlm.nih.gov/10219066/ DOI: 10.1056/nejm199904293401703
    Complete structured claim and evidence

What acts on it

  1. In the mouse tracer experiments, labeled D-chiro-inositol was not detected after heavy-water exposure or deuterated myo-inositol administration.

    Myo-inositol → D-chiro-inositol source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/19586572.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26", "start_char": 0, "end_char": 1544, "text_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26"}
    experimental_model
    Dietary balance, GC-MS and stable-isotope tracing
    exposure
    Defined diets, heavy water and deuterated myo-inositol/DCI
    limitations
    Failure to detect conversion in mice does not exclude all human or isolated-tissue activity. Isotope strategy, chemical identification, species and dietary DCI contamination may contribute to disagreement with earlier radiotracer reports.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Rats and mice; conversion tracing in mice
    plain_language
    This study did not reproduce the proposed endogenous conversion route in its mouse experiments.
    primary_references
    [ino-p19586572] d- chiro-Inositol is absorbed but not synthesised in rodents. (2009). https://pubmed.ncbi.nlm.nih.gov/19586572/ DOI: 10.1017/s0007114509990456
    tissue_or_cell_type
    Gastrointestinal absorption, plasma and excreta

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1224–1235

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Dietary balance, GC-MS and stable-isotope tracing · source_derived_draft · unverified_draft

    ### ino-dci-no-conversion In the mouse tracer experiments, labeled D-chiro-inositol was not detected after heavy-water exposure or deuterated myo-inositol administration. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: This study did not reproduce the proposed endogenous conversion route in its mouse experiments. organism: Rats and mice; conversion tracing in mice tissue_or_cell_type: Gastrointestinal absorption, plasma and excreta experimental_model: Dietary balance, GC-MS and stable-isotope tracing limitations: Failure to detect conversion in mice does not exclude all human or isolated-tissue activity. Isotope strategy, chemical identification, species and dietary DCI contamination may contribute to disagreement with earlier radiotracer reports. exposure: Defined diets, heavy water and deuterated myo-inositol/DCI evidence_span: {"source_cache": "artifacts/inositol-research/19586572.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26", "start_char": 0, "end_char": 1544, "text_sha256": "7c6e57e631fef5921afd04f75718024d5b14ca525460e2c96275a4fc320c3b26"} [ino-p19586572] d- chiro-Inositol is absorbed but not synthesised in rodents. (2009). https://pubmed.ncbi.nlm.nih.gov/19586572/ DOI: 10.1017/s0007114509990456
    Complete structured claim and evidence
  2. Human SMIT2 expression increased D-chiro-inositol uptake 159-fold in rat L6 cells.

    SLC5A11 (human SMIT2) → D-chiro-inositol source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/19032932.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4fdc565b9aa26ef5f2d083c539a1b0367403b39f0c75d3ea1b194bf6fa525242", "start_char": 0, "end_char": 1164, "text_sha256": "4fdc565b9aa26ef5f2d083c539a1b0367403b39f0c75d3ea1b194bf6fa525242"}
    experimental_model
    Human SMIT2 overexpression and radiotracer uptake
    exposure
    Overexpression, glucose competition and insulin exposure
    limitations
    Overexpression is not normal transporter abundance. Insulin experiments used untransfected rat cells; changes in human diabetes are proposed, not demonstrated here.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Human transporter in rat L6 myoblasts
    plain_language
    The transporter can carry a second inositol stereoisomer.
    primary_references
    [ino-p19032932] Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. (2009). https://pubmed.ncbi.nlm.nih.gov/19032932/ DOI: 10.1016/j.abb.2008.11.008
    tissue_or_cell_type
    Skeletal-muscle cell model
    transport_effect
    raises Expression increased D-chiro-inositol uptake 159-fold.
    transport_pool
    the expressing cell Expression increased D-chiro-inositol uptake 159-fold.

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 301–312

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human SMIT2 overexpression and radiotracer uptake · source_derived_draft · unverified_draft

    ### ino-smit2-dci Human SMIT2 expression increased D-chiro-inositol uptake 159-fold in rat L6 cells. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: The transporter can carry a second inositol stereoisomer. organism: Human transporter in rat L6 myoblasts tissue_or_cell_type: Skeletal-muscle cell model experimental_model: Human SMIT2 overexpression and radiotracer uptake limitations: Overexpression is not normal transporter abundance. Insulin experiments used untransfected rat cells; changes in human diabetes are proposed, not demonstrated here. exposure: Overexpression, glucose competition and insulin exposure evidence_span: {"source_cache": "artifacts/inositol-research/19032932.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4fdc565b9aa26ef5f2d083c539a1b0367403b39f0c75d3ea1b194bf6fa525242", "start_char": 0, "end_char": 1164, "text_sha256": "4fdc565b9aa26ef5f2d083c539a1b0367403b39f0c75d3ea1b194bf6fa525242"} [ino-p19032932] Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. (2009). https://pubmed.ncbi.nlm.nih.gov/19032932/ DOI: 10.1016/j.abb.2008.11.008
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Rat liver cytosol contained activity converting myo-inositol to D-chiro-inositol.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/12051772.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "28ae1225b489898738997d2376ab09857f017314086979032d3ad907299a1154", "start_char": 0, "end_char": 2218, "text_sha256": "28ae1225b489898738997d2376ab09857f017314086979032d3ad907299a1154"}
    experimental_model
    Radiotracer conversion and cytosolic enzyme assays
    exposure
    Diabetic rat versus controls; reduced pyridine-nucleotide cofactors
    limitations
    The molecular identity of the activity was not established here. A later mouse stable-isotope study found no myo-to-D-chiro conversion; the research disagreement is recorded separately. Do not invent a human epimerase gene or infer a universal supplement ratio.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Goto-Kakizaki and Wistar rats
    plain_language
    One stereoisomer can be converted into another in this rat tissue preparation.
    primary_references
    [ino-p12051772] Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. (2002). https://pubmed.ncbi.nlm.nih.gov/12051772/ DOI: 10.1016/s0006-291x(02)00313-3
    tissue_or_cell_type
    Liver, muscle, kidney and adipose preparations

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1172–1183

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiotracer conversion and cytosolic enzyme assays · source_derived_draft · unverified_draft

    ### ino-rat-epimerase Rat liver cytosol contained activity converting myo-inositol to D-chiro-inositol. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: One stereoisomer can be converted into another in this rat tissue preparation. organism: Goto-Kakizaki and Wistar rats tissue_or_cell_type: Liver, muscle, kidney and adipose preparations experimental_model: Radiotracer conversion and cytosolic enzyme assays limitations: The molecular identity of the activity was not established here. A later mouse stable-isotope study found no myo-to-D-chiro conversion; the research disagreement is recorded separately. Do not invent a human epimerase gene or infer a universal supplement ratio. exposure: Diabetic rat versus controls; reduced pyridine-nucleotide cofactors evidence_span: {"source_cache": "artifacts/inositol-research/12051772.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "28ae1225b489898738997d2376ab09857f017314086979032d3ad907299a1154", "start_char": 0, "end_char": 2218, "text_sha256": "28ae1225b489898738997d2376ab09857f017314086979032d3ad907299a1154"} [ino-p12051772] Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. (2002). https://pubmed.ncbi.nlm.nih.gov/12051772/ DOI: 10.1016/s0006-291x(02)00313-3
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards